PTEN and colorectal carcinoma: In this context, the role of PTEN as a potential prognostic and/or predictive biomarker in CRC remains debated, not only in terms of response to established therapeutic approaches, such EGF receptor (EGFR) and/or VEGF receptor blockade (6, 7), but also in reference to experimental PI3K pathway inhibition.